ArticleF1000Research2024

Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders.

Abigail Schweiger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.